Successful targeting of the <i>NRG1</i> fusion reveals durable response to afatinib in lung adenocarcinoma: a case report.

Wu, Xiaokang; Zhang, Dongqing; Shi, Mengru; Wang, Fang; Li, Yuping; Lin, Quan

Successful targeting of the NRG1 fusion reveals durable response to afatinib in lung adenocarcinoma: a case report.

Wu, Xiaokang; Zhang, Dongqing; Shi, Mengru; Wang, Fang; Li, Yuping; Lin, Quan.

Afiliação

Wu X; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zhang D; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Shi M; Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.
Wang F; Department of Pathology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Li Y; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Lin Q; Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Ann Transl Med ; 9(19): 1507, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34805369

Palavras-chave

Lung adenocarcinoma; afatinib; case report; neuregulin 1 gene (NRG1) fusion; next-generation sequencing (NGS)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Ann Transl Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google